Early life exposure to measles and later-life outcomes: Evidence from the introduction of a vaccine
Gerard J. van den Berg,
Stephanie von Hinke and
Papers from arXiv.org
Until the mid 1960s, the UK experienced regular measles epidemics, with the vast majority of children being infected in early childhood. The introduction of a measles vaccine substantially reduced its incidence. The first part of this paper examines the long-term human capital and health effects of this change in the early childhood disease environment. The second part investigates interactions between the vaccination campaign and individuals' endowments as captured using molecular genetic data, shedding light on complementarities between public health investments and individual endowments. We use two identification approaches, based on the nationwide introduction of the vaccine in 1968 and local vaccination trials in 1966. Our results show that exposure to the vaccination in early childhood positively affects adult height, but only among those with high genetic endowments for height. We find no effects on years of education; neither a direct effect, nor evidence of complementarities.
New Economics Papers: this item is included in nep-hea and nep-his
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
http://arxiv.org/pdf/2301.10558 Latest version (application/pdf)
Working Paper: Early life exposure to measles and later-life outcomes: Evidence from the introduction of a vaccine (2023)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:arx:papers:2301.10558
Access Statistics for this paper
More papers in Papers from arXiv.org
Bibliographic data for series maintained by arXiv administrators ().